Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Biocytogen and Hansoh Pharma Announce an Antibody License Agreement
Biocytogen Pharmaceuticals (Beijing), a clinical-stage biotechnology company with a focus on the antibody discovery and […]
PVmed Raises US $14 Million Series A Funding
Perception Vision Medical Technologies (PVmed), a global artificial intelligence (AI) cancer treatment company, headquartered in […]
Vivera Welcomes CPG Leader Karen Antonio to its Advisory Board
Direct-to-consumer, consumer packaged goods (CPG), business development, and retail distribution expert Karen Antonio has joined Vivera […]
Merck and Kelun-Biotech Announce Exclusive License and Collaboration Agreement for Seven Investigational Antibody-drug Conjugate Candidates for the Treatment of Cancer
Merck, known as MSD outside of the United States and Canada, and Kelun-Biotech, a clinical-stage […]
HealthTech Arkansas and Laina Enterprises Partner to Provide Clinical Trial Software to the BioAR Trial Accelerator Participants
HealthTech Arkansas and Laina Enterprises have partnered to provide support to the biotherapeutics startup companies […]
Vistagen to Acquire Pherin Pharmaceuticals
Vistagen, a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living […]
Anocca Secures €25 Million from the European Investment Bank to Support Development of T-cell Therapies for Cancer
Anocca, a fully integrated cell therapy biotechnology company, has announced that it has secured €25 […]
Biomica Raises $20 Million in a Funding Round to Advance its Pipeline of Microbiome-based Therapeutics
Biomica, a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene, has […]
Drug Safety Prediction AI Startup Quris Earns Additional Seed Funding Led by SoftBank Vision Fund 2
Quris, an artificial intelligence (AI) innovator disrupting the pharmaceutical arena, has announced it has secured […]
Kite to Acquire Tmunity Therapeutics to Pursue Next Generation CAR T-Cell Therapy Advancements in Cancer
Kite and Tmunity Therapeutics have announced that the companies have signed an agreement in which […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more